| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0009 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.097 | 0.001 |